nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—DRD4—conduct disorder	0.583	0.685	CbGaD
Cabergoline—HTR2A—conduct disorder	0.269	0.316	CbGaD
Cabergoline—HTR7—autonomic nervous system—conduct disorder	0.00375	0.248	CbGeAlD
Cabergoline—Pergolide—DRD4—conduct disorder	0.00267	0.366	CrCbGaD
Cabergoline—HTR2A—autonomic nervous system—conduct disorder	0.00234	0.155	CbGeAlD
Cabergoline—Lisuride—DRD4—conduct disorder	0.00232	0.318	CrCbGaD
Cabergoline—Pergolide—HTR2A—conduct disorder	0.00123	0.169	CrCbGaD
Cabergoline—DRD4—brain—conduct disorder	0.00115	0.0762	CbGeAlD
Cabergoline—Lisuride—HTR2A—conduct disorder	0.00107	0.147	CrCbGaD
Cabergoline—DRD3—brain—conduct disorder	0.000811	0.0536	CbGeAlD
Cabergoline—DRD5—brain—conduct disorder	0.00076	0.0502	CbGeAlD
Cabergoline—ADRA1B—brain—conduct disorder	0.000623	0.0412	CbGeAlD
Cabergoline—ADRA1D—brain—conduct disorder	0.000609	0.0403	CbGeAlD
Cabergoline—DRD1—brain—conduct disorder	0.00058	0.0384	CbGeAlD
Cabergoline—HTR1B—brain—conduct disorder	0.00047	0.0311	CbGeAlD
Cabergoline—HTR1D—brain—conduct disorder	0.000455	0.0301	CbGeAlD
Cabergoline—HTR2C—brain—conduct disorder	0.000451	0.0298	CbGeAlD
Cabergoline—ADRB1—brain—conduct disorder	0.000442	0.0292	CbGeAlD
Cabergoline—HTR2B—brain—conduct disorder	0.000424	0.028	CbGeAlD
Cabergoline—HTR1A—brain—conduct disorder	0.00038	0.0251	CbGeAlD
Cabergoline—HTR7—brain—conduct disorder	0.000363	0.024	CbGeAlD
Cabergoline—ADRA1A—brain—conduct disorder	0.00035	0.0231	CbGeAlD
Cabergoline—DRD2—brain—conduct disorder	0.000343	0.0227	CbGeAlD
Cabergoline—ADRA2C—brain—conduct disorder	0.000333	0.022	CbGeAlD
Cabergoline—ADRA2A—brain—conduct disorder	0.000266	0.0176	CbGeAlD
Cabergoline—HTR2A—brain—conduct disorder	0.000226	0.0149	CbGeAlD
Cabergoline—ADRB1—Signaling by GPCR—CGA—conduct disorder	9.23e-05	0.000732	CbGpPWpGaD
Cabergoline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.17e-05	0.000728	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	9.17e-05	0.000728	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—CGA—conduct disorder	9.14e-05	0.000726	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CGA—conduct disorder	9.12e-05	0.000724	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—CGA—conduct disorder	9.02e-05	0.000716	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—CGA—conduct disorder	8.82e-05	0.0007	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—CGA—conduct disorder	8.78e-05	0.000697	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—DRD4—conduct disorder	8.65e-05	0.000687	CbGpPWpGaD
Cabergoline—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.63e-05	0.000685	CbGpPWpGaD
Cabergoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.55e-05	0.000678	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—CGA—conduct disorder	8.54e-05	0.000678	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—CGA—conduct disorder	8.53e-05	0.000677	CbGpPWpGaD
Cabergoline—HTR7—GPCR ligand binding—HTR2A—conduct disorder	8.48e-05	0.000673	CbGpPWpGaD
Cabergoline—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.45e-05	0.000671	CbGpPWpGaD
Cabergoline—DRD2—GPCR ligand binding—DRD4—conduct disorder	8.45e-05	0.000671	CbGpPWpGaD
Cabergoline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.44e-05	0.00067	CbGpPWpGaD
Cabergoline—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	8.42e-05	0.000669	CbGpPWpGaD
Cabergoline—HTR7—Circadian rythm related genes—EP300—conduct disorder	8.41e-05	0.000667	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—CGA—conduct disorder	8.4e-05	0.000667	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.39e-05	0.000666	CbGpPWpGaD
Cabergoline—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.32e-05	0.00066	CbGpPWpGaD
Cabergoline—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.25e-05	0.000655	CbGpPWpGaD
Cabergoline—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	8.25e-05	0.000655	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.22e-05	0.000653	CbGpPWpGaD
Cabergoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.21e-05	0.000652	CbGpPWpGaD
Cabergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.15e-05	0.000647	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	8.15e-05	0.000647	CbGpPWpGaD
Cabergoline—DRD4—GPCR ligand binding—HTR2A—conduct disorder	8.12e-05	0.000644	CbGpPWpGaD
Cabergoline—DRD4—Circadian rythm related genes—EP300—conduct disorder	8.05e-05	0.000639	CbGpPWpGaD
Cabergoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.98e-05	0.000634	CbGpPWpGaD
Cabergoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.86e-05	0.000624	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—CGA—conduct disorder	7.75e-05	0.000615	CbGpPWpGaD
Cabergoline—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	7.75e-05	0.000615	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	7.64e-05	0.000606	CbGpPWpGaD
Cabergoline—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.63e-05	0.000606	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—CGA—conduct disorder	7.62e-05	0.000605	CbGpPWpGaD
Cabergoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.57e-05	0.000601	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	7.57e-05	0.000601	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.46e-05	0.000593	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—DRD4—conduct disorder	7.34e-05	0.000583	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—WASF1—conduct disorder	7.31e-05	0.00058	CbGpPWpGaD
Cabergoline—DRD1—GPCR ligand binding—HTR2A—conduct disorder	7.31e-05	0.00058	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.3e-05	0.000579	CbGpPWpGaD
Cabergoline—DRD1—Circadian rythm related genes—EP300—conduct disorder	7.24e-05	0.000575	CbGpPWpGaD
Cabergoline—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.24e-05	0.000575	CbGpPWpGaD
Cabergoline—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.21e-05	0.000572	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.21e-05	0.000572	CbGpPWpGaD
Cabergoline—DRD3—Circadian rythm related genes—EP300—conduct disorder	7.15e-05	0.000567	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	7.14e-05	0.000567	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CGA—conduct disorder	7.03e-05	0.000558	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CGA—conduct disorder	6.99e-05	0.000555	CbGpPWpGaD
Cabergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.98e-05	0.000554	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—CGA—conduct disorder	6.94e-05	0.000551	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CGA—conduct disorder	6.84e-05	0.000543	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CGA—conduct disorder	6.73e-05	0.000535	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	6.71e-05	0.000533	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—DRD4—conduct disorder	6.67e-05	0.000529	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—DRD4—conduct disorder	6.62e-05	0.000526	CbGpPWpGaD
Cabergoline—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.59e-05	0.000523	CbGpPWpGaD
Cabergoline—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	6.57e-05	0.000521	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.51e-05	0.000517	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—DRD4—conduct disorder	6.49e-05	0.000515	CbGpPWpGaD
Cabergoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.48e-05	0.000515	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CGA—conduct disorder	6.43e-05	0.00051	CbGpPWpGaD
Cabergoline—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	6.43e-05	0.00051	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—DRD4—conduct disorder	6.33e-05	0.000502	CbGpPWpGaD
Cabergoline—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.28e-05	0.000499	CbGpPWpGaD
Cabergoline—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.25e-05	0.000496	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.24e-05	0.000496	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.24e-05	0.000496	CbGpPWpGaD
Cabergoline—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	6.21e-05	0.000493	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—DRD4—conduct disorder	6.09e-05	0.000484	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.08e-05	0.000483	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CGA—conduct disorder	6.06e-05	0.000481	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—CGA—conduct disorder	6.03e-05	0.000479	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	5.98e-05	0.000475	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CGA—conduct disorder	5.98e-05	0.000475	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CGA—conduct disorder	5.98e-05	0.000475	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—DRD4—conduct disorder	5.75e-05	0.000456	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	5.69e-05	0.000452	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.67e-05	0.00045	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	5.67e-05	0.00045	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—HTR2A—conduct disorder	5.64e-05	0.000448	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—WASF1—conduct disorder	5.64e-05	0.000448	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	5.64e-05	0.000448	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—WASF1—conduct disorder	5.6e-05	0.000445	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	5.57e-05	0.000442	CbGpPWpGaD
Cabergoline—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.52e-05	0.000438	CbGpPWpGaD
Cabergoline—CYP3A4—Biological oxidations—COMT—conduct disorder	5.51e-05	0.000437	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—WASF1—conduct disorder	5.48e-05	0.000435	CbGpPWpGaD
Cabergoline—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.47e-05	0.000434	CbGpPWpGaD
Cabergoline—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.47e-05	0.000434	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CGA—conduct disorder	5.45e-05	0.000433	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.44e-05	0.000432	CbGpPWpGaD
Cabergoline—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.43e-05	0.000431	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.41e-05	0.00043	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.4e-05	0.000429	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—WASF1—conduct disorder	5.4e-05	0.000428	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CGA—conduct disorder	5.33e-05	0.000423	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.31e-05	0.000422	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.27e-05	0.000418	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CGA—conduct disorder	5.21e-05	0.000414	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CGA—conduct disorder	5.19e-05	0.000412	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.18e-05	0.000411	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—DRD4—conduct disorder	5.17e-05	0.00041	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.15e-05	0.000409	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.12e-05	0.000406	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—DRD4—conduct disorder	5.11e-05	0.000406	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—DRD4—conduct disorder	5.05e-05	0.000401	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.04e-05	0.0004	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CGA—conduct disorder	4.96e-05	0.000394	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—DRD4—conduct disorder	4.94e-05	0.000392	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	4.94e-05	0.000392	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.92e-05	0.00039	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—CGA—conduct disorder	4.9e-05	0.000389	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—WASF1—conduct disorder	4.86e-05	0.000386	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—WASF1—conduct disorder	4.79e-05	0.000381	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—WASF1—conduct disorder	4.79e-05	0.000381	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	4.79e-05	0.00038	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	4.78e-05	0.00038	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.78e-05	0.000379	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	4.76e-05	0.000378	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	4.71e-05	0.000374	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.7e-05	0.000373	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	4.66e-05	0.00037	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.6e-05	0.000365	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.59e-05	0.000364	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CGA—conduct disorder	4.58e-05	0.000363	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CGA—conduct disorder	4.5e-05	0.000357	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.41e-05	0.00035	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.38e-05	0.000348	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—WASF1—conduct disorder	4.37e-05	0.000347	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—HTR2A—conduct disorder	4.35e-05	0.000345	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.34e-05	0.000344	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.33e-05	0.000344	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.32e-05	0.000343	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.28e-05	0.00034	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—WASF1—conduct disorder	4.27e-05	0.000339	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.27e-05	0.000339	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.23e-05	0.000336	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.18e-05	0.000332	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.18e-05	0.000332	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.16e-05	0.000331	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.16e-05	0.00033	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.13e-05	0.000328	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.1e-05	0.000325	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.07e-05	0.000323	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.07e-05	0.000323	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.04e-05	0.000321	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—WASF1—conduct disorder	3.98e-05	0.000316	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	3.98e-05	0.000316	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—DRD4—conduct disorder	3.94e-05	0.000313	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—DRD4—conduct disorder	3.91e-05	0.000311	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	3.88e-05	0.000308	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—DRD4—conduct disorder	3.83e-05	0.000304	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—HTR2A—conduct disorder	3.75e-05	0.000298	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	3.71e-05	0.000295	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.7e-05	0.000294	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.7e-05	0.000294	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.68e-05	0.000292	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—WASF1—conduct disorder	3.67e-05	0.000291	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	3.63e-05	0.000288	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.61e-05	0.000287	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.6e-05	0.000286	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.55e-05	0.000282	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.53e-05	0.000281	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.53e-05	0.00028	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.44e-05	0.000273	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—DRD4—conduct disorder	3.39e-05	0.000269	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.38e-05	0.000268	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	3.37e-05	0.000268	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—DRD4—conduct disorder	3.35e-05	0.000266	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.35e-05	0.000266	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.34e-05	0.000265	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—HTR2A—conduct disorder	3.33e-05	0.000265	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	3.3e-05	0.000262	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.28e-05	0.000261	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.22e-05	0.000256	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.21e-05	0.000255	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.12e-05	0.000248	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.12e-05	0.000247	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—EP300—conduct disorder	3.08e-05	0.000245	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.07e-05	0.000244	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—DRD4—conduct disorder	3.05e-05	0.000242	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.02e-05	0.00024	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3e-05	0.000238	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—DRD4—conduct disorder	2.99e-05	0.000237	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.92e-05	0.000232	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.9e-05	0.000231	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—EP300—conduct disorder	2.88e-05	0.000229	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.83e-05	0.000225	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.82e-05	0.000224	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.79e-05	0.000222	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.78e-05	0.000221	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.73e-05	0.000217	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—COMT—conduct disorder	2.72e-05	0.000216	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—MAOA—conduct disorder	2.7e-05	0.000215	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.57e-05	0.000204	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—DRD4—conduct disorder	2.56e-05	0.000203	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.55e-05	0.000203	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.53e-05	0.000201	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.52e-05	0.0002	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.5e-05	0.000198	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.47e-05	0.000196	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.46e-05	0.000195	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.35e-05	0.000186	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—EP300—conduct disorder	2.34e-05	0.000186	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.29e-05	0.000182	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.21e-05	0.000176	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—COMT—conduct disorder	2.21e-05	0.000176	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—MAOA—conduct disorder	2.2e-05	0.000174	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.19e-05	0.000173	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.19e-05	0.000173	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CGA—conduct disorder	2.09e-05	0.000166	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.99e-05	0.000158	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.97e-05	0.000157	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HTR2A—conduct disorder	1.95e-05	0.000155	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.9e-05	0.000151	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.89e-05	0.00015	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.84e-05	0.000146	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.81e-05	0.000144	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—EP300—conduct disorder	1.77e-05	0.00014	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.67e-05	0.000133	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.61e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.5e-05	0.000119	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—EP300—conduct disorder	1.36e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000107	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—EP300—conduct disorder	1.32e-05	0.000105	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—EP300—conduct disorder	1.3e-05	0.000103	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EP300—conduct disorder	1.24e-05	9.88e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EP300—conduct disorder	1.17e-05	9.32e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—EP300—conduct disorder	1.17e-05	9.27e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EP300—conduct disorder	1.16e-05	9.19e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.16e-05	9.19e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EP300—conduct disorder	1.05e-05	8.37e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.05e-05	8.3e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EP300—conduct disorder	1.03e-05	8.19e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EP300—conduct disorder	1.01e-05	8.01e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EP300—conduct disorder	1e-05	7.97e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EP300—conduct disorder	9.76e-06	7.75e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EP300—conduct disorder	9.61e-06	7.63e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—EP300—conduct disorder	9.48e-06	7.53e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—COMT—conduct disorder	9.42e-06	7.48e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MAOA—conduct disorder	9.36e-06	7.43e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EP300—conduct disorder	8.86e-06	7.03e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EP300—conduct disorder	8.72e-06	6.92e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.54e-06	6.78e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EP300—conduct disorder	7.93e-06	6.3e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—EP300—conduct disorder	4.04e-06	3.21e-05	CbGpPWpGaD
